Other
Chordoma
24
Pipeline Programs↗
6
Active Trials↗
12
Companies Involved↗
Chordoma is an emerging landscape with 24 programs across 12 companies. The most active players are Eagle Vision Pharmaceutical Corp., Azurity Pharmaceuticals, Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 13
Phase 221
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
19programs
Small molecule1053%
Monoclonal antibody526%
Protein / enzyme316%
Vaccine15%
Modality classified for 100% of 24 pipeline programs.
Analysis
Trial Status
20
clinical trials
Completed9 · 45%
Unknown status4 · 20%
Recruiting4 · 20%
Active, not recruiting2 · 10%
Withdrawn1 · 5%
Clinical Trials
Trial Activity
20 trials
Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma
Active, not recruiting·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 1·NCT02989636·21 enrolled
BN Brachyury and Radiation in Chordoma
Completed·—·Phase 2·NCT03595228·29 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)